Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Ridgway

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Diabetes|December 21, 2013
A new tool for dissecting genetic control of type 1 diabetesWilliam M Ridgway
Immunologic Research|March 6, 2007
Dissecting genetic control of autoimmunity in NOD congenic miceWilliam M Ridgway
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responsesWilliam M Ridgway
Immunotargets and Therapy|June 6, 2017
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetesArata Itoh, William M Ridgway
The Keio Journal of Medicine|October 21, 2005
A modular theory of autoimmunityJunichiro Irie, William M Ridgway
Hepatology (Baltimore, Md.)|May 15, 2014
Prometheus unbound: NKT cells inhibit hepatic regenerationWilliam M Ridgway, M Eric Gershwin
Immunotherapy|December 20, 2014
Targeting innate immunity for treatment of type 1 diabetesKyle J Bednar, William M Ridgway
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic backgroundSyuichi Koarada, Yuehong Wu, Grace Olshansky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
The non-obese diabetic (NOD) mouse as a model of human type 1 diabetesKritika Kachapati, David Adams, Kyle Bednar, et al.
Immunogenetics|January 21, 2006
Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 regionJunichiro Irie, Yuehong Wu, David A Sass, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Diabetes|December 21, 2013
A new tool for dissecting genetic control of type 1 diabetesWilliam M Ridgway
Immunologic Research|March 6, 2007
Dissecting genetic control of autoimmunity in NOD congenic miceWilliam M Ridgway
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responsesWilliam M Ridgway
Immunotargets and Therapy|June 6, 2017
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetesArata Itoh, William M Ridgway
The Keio Journal of Medicine|October 21, 2005
A modular theory of autoimmunityJunichiro Irie, William M Ridgway
Hepatology (Baltimore, Md.)|May 15, 2014
Prometheus unbound: NKT cells inhibit hepatic regenerationWilliam M Ridgway, M Eric Gershwin
Immunotherapy|December 20, 2014
Targeting innate immunity for treatment of type 1 diabetesKyle J Bednar, William M Ridgway
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic backgroundSyuichi Koarada, Yuehong Wu, Grace Olshansky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
The non-obese diabetic (NOD) mouse as a model of human type 1 diabetesKritika Kachapati, David Adams, Kyle Bednar, et al.
Immunogenetics|January 21, 2006
Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 regionJunichiro Irie, Yuehong Wu, David A Sass, et al.
Pageof 9